Horowitz: CDC warns of monkeypox outbreak from ‘festivals.’ Solution? More ineffective vaccines!
We were told that all human life had to cease to function indefinitely for a virus that was impossible to quarantine. Public health goals, they lectured us, trump all human rights, civil society, and economic considerations. Yet when it comes to monkeypox, which is not only quarantinable but completely avoidable, our government refuses to simply cancel the one thing that spreads it – anal sex orgies. Instead, officials weaponize the rainbow jihad planned for the month of June to further promote experimental vaccines that are inefficient and might be as problematic as the COVID shots.
Last week, the CDC issued an alert warning, “Spring and summer season in 2023 could lead to a resurgence of mpox as people gather for festivals and other events.” Interestingly enough, most viruses spread in the winter and not because of “festivals,” but what they won’t publicly say is that this obsession with sodomy pride in the month of June provides numerous opportunities to spread the virus through a sacrament that is unassailable in “public health” circles.
You see, your parent or grandparent had to die alone and be buried without a funeral, even though there was no sign that you were a threat to someone. A rape victim who tested negative for COVID had to wear a trauma-inducing cloth on her month just to see a doctor for years and, in some cases, to this very day. Yet our government refuses to flag, much less cancel, the one act that actually spreads monkeypox. Instead, it is promoting an experimental JYNNEOS vaccine that was repurposed from smallpox and has never undergone a full clinical trial.
“Mpox vaccination should be offered to people with high potential for exposure to mpox,” recommends the “Center for Disinformation and Conceit.”
Yet, in the same press release, the CDC notes that the impetus for the health alert is a cluster of 13 cases in Chicago of which “nine (69%) of 13 cases were among men who had received 2 JYNNEOS vaccine doses.” COVID de ja vu all over again! The solution is to get vaccinated with a shot that doesn’t work rather than to simply state the plain truth about the origins of the problem they now call “mpox.” Of course, all 13 individuals were males. Surprise, surprise, a very special virus that doesn’t attack females!
Nine out of 13 individuals infected being vaccinated is an astounding ratio for something touted as 90% effective, given how relatively few people have even gotten this shot. So clearly this is a leaky, non-sterilizing vaccine with waning antibodies.
Stop for a moment and review some of the information we learned about leaky, non-sterilizing vaccines from the COVID experience. In theory, a vaccine that worked to stop serious illness but not transmission would be worth pursuing, but when it comes to microbiology, non-sterilizing vaccines run the risk of making matters worse and causing negative efficacy. As Quanta magazine warned in 2018:
The problem with leaky vaccines, Read says, is that they enable pathogens to replicate unchecked while also protecting hosts from illness and death, thereby removing the costs associated with increased virulence. Over time, then, in a world of leaky vaccinations, a pathogen might evolve to become deadlier to unvaccinated hosts because it can reap the benefits of virulence without the costs — much as Marek’s disease has slowly become more lethal to unvaccinated chickens. This virulence can also cause the vaccine to start failing by causing illness in vaccinated hosts.
It's this phenomenon that has plagued the unsuccessful attempts to create vaccines for HIV, malaria, and anthrax. Remember, the CDC claimed JYNNEOS was 90% effective, yet now it is warning of outbreaks among those with two doses! Despite all of these failures, the hurdles to previous vaccines are now ignored in the new regime, in which officials are approving new dubious shots at warp speed.
Aside from the concerns with negative efficacy, there are some serious safety problems with the monkeypox vaccine, which has already been given to over 1 million people. JYNNEOS was randomly expedited for full approval in 2021 without any clinical trials, just based on immune-bridging (measuring of antibody titers)! So what do we know about it?
On the actual FDA label of the JYNNEOS vaccine (p. 6), it reveals that 1.2% of all recipients in a trial experienced “cardiac adverse events of special interest”! The number was as high as 2.1% for those who already had the smallpox vaccine at some time in their lives.
Meanwhile, last week, the FDA’s Vaccines and Related Biological Products Advisory Committee approved Pfizer’s very problematic RSV shot for pregnant women! Paul Offit, famed vaccinologist at the Children’s Hospital of Philadelphia and member of VRBPAC, voted against it and warned that an almost identical vaccine was suspended for similar safety concerns to those indicated in Pfizer’s trial.